VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT
VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT
Recruiting · NCT06447090 · Registry updated 2024-06-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT | Relapse Acute Myeloid Leukemia | Recruiting | Phase 2 | 2024-06-06 | NCT06447090 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 285 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | Tianjin | China | 1 |